COMPASS PATHWAYS INC.

Lobbying for COMPASS PATHWAYS INC. · Biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $130,000.00 expenses · posted Jul 17, 2026

Lobbying activity 1

Budget/Appropriations

Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines. Issues pertaining to controlled substances rescheduling

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.